8 hours ago
1
Click_and_Photo
- Truist initiated coverage of diabetes care firms DexCom (NASDAQ:DXCM), and Insulet (NASDAQ:PODD) at buy, and Tandem Diabetes Care (NASDAQ:TNDM) at hold, citing potential market growth and feedback from doctors.
- While DexCom has a "cheaper relative valuation" compared to Insulet, according to analyst Richard
English (US) ·